A recent report published by Infinium Global Research on urinary tract infection market provides an in-depth analysis of segments and sub-segments in the global as well as regional urinary tract infection market.

Pune, India -- (SBWire) -- 11/29/2019 --Infinium Global Research has recently published a report on the "Urinary Tract Infection Market (Drug Class - Quinolones, Aminoglycosides, ?-lactam, Azoles, and Other Drug Class; Clinical Indications - Cystitis, Urethritis, Pyelonephritis, and Other Clinical Indications; End User - Hospitals, Self-administered, and Other End Users): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025." The global urinary tract infection market is projected to grow at a CAGR of 3.5% over the forecast period of 2019-2025.

Get Sample Report Copy for Market Insights @ https://www.infiniumglobalresearch.com/reports/sample-request/12966

According to the IGR research analysts, rising hospital-borne infections driving the growth of the urinary tract infection market. Urinary tract infections account for a significant share of all hospital-acquired infections. The associated morbidity and mortality are a major drain on hospital resources. Patients with indwelling urinary catheters, patients undergoing urological manipulations, long-stay elderly male patients, and patients with debilitating diseases are at high risk of developing nosocomial UTIs. Around 150 million people get affected by Urinary tract infection each year, Urinary tract infection is prominent in women; around 60 percent compared to men.

North America is Expected to Dominate the Market During the Forecast Period

The report gives an in-depth analysis of the urinary tract infection market, focuses on market opportunities along with the trends driving the market. It provides the market segmentation by drug class (quinolones, aminoglycosides, ?-lactam, azoles, and other drugs), by clinical indications (cystitis, Urethritis, Pyelonephritis, Other Clinical Indications), by end-user (hospitals, self-administered, other end-users) and by geography. Geographically, the urinary tract infection market segmented by North America, Europe, Asia Pacific, and RoW. Among these, North America is anticipated to stay at the top position in the global market. Rising prevalence of urinary tract infection primarily because of diseases such as diabetes, high rate of diagnosis, and increasing awareness about urinary tract infection are such factors contributing to the growth of the market in this region. 

Enquire here Get Customization & Check Discount for Report @ https://www.infiniumglobalresearch.com/reports/request-discount/12966

Urinary Tract Infection Market: Competitive Analysis

The key players profiled in the report are Merck & Co., Inc., Bayer AG, Johnson & Johnson, Novartis AG, Allergan plc, AstraZeneca plc, Mylan N.V., Novo Nordisk A/S, Sun Pharmaceuticals ltd., and Other companies. The FDA designates Allergan's ATM-AVI (aztreonam and avibactam) a Qualified Infectious Disease Product (QIDP) for Fast Track review for the treatment of complicated intra-abdominal infections, complicated urinary tract infections and hospital-acquired bacterial pneumonia/ventilator-associated bacterial pneumonia.

About Us

The Infinium Global Research comprises of a team of well-experienced analysts who have qualified in generating the incisive report. The urinary tract infection market report offers trends, opportunities, challenges, market size, and forecast for major geographical regions and key countries. This report studies the urinary tract infection market in the global market, especially in Europe, North America, and Asia-pacific and RoW with production, revenue, consumption, import, and export in these regions.

Read Detailed Index of full Research Study of https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-urinary-tract-infection-market

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of the urinary tract infection.

=> Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2025.

=> Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.  

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.